What are Robert F. Friel’s Xylem (XYL) share holdings after this grant?

Following the award, the filing states that Robert F. Friel directly holds 38,706 Xylem common shares. This figure includes additional shares attributed through dividend reinvestment, reflecting both prior holdings and the impact of the new restricted stock unit grant.

RSU grant adds 2,481 Xylem (NYSE: XYL) director shares

Filing Impact

(Moderate)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

FRIEL ROBERT F reported acquisition or exercise transactions in this Form 4 filing.

Xylem Inc. director Robert F. Friel received an equity award in the form of 2,481 shares of common stock, reported as a grant of restricted stock units valued at $116.88 per share. After this award, he directly holds 38,706 shares, including amounts credited through dividend reinvestment.

The award was granted under the Xylem 2011 Omnibus Incentive Plan and is scheduled to vest in full on the trading day before the 2027 Annual Meeting of Shareholders. Friel has elected to defer settlement of this RSU award until his Separation from Service, meaning he will receive the underlying shares at that later time rather than at vesting.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider FRIEL ROBERT F

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	2,481	$116.88	$290K

Holdings After Transaction: Common Stock — 38,706 shares (Direct, null)

Footnotes (1)

Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service. Includes additional shares due to dividend reinvestment.

Key Figures

RSU shares granted: 2,481 shares Grant reference price: $116.88 per share Shares held after award: 38,706 shares +1 more

4 metrics

RSU shares granted 2,481 shares Restricted stock unit award to director Robert F. Friel

Grant reference price $116.88 per share Value per share used for the RSU award

Shares held after award 38,706 shares Direct Xylem common stock holdings after the grant

Vesting timing Trading day prior to 2027 Annual Meeting Scheduled vesting date for the RSU award

Key Terms

restricted stock units, Xylem 2011 Omnibus Incentive Plan, dividend reinvestment, Separation from Service

4 terms

restricted stock units financial

"Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Xylem 2011 Omnibus Incentive Plan financial

"Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016)"

dividend reinvestment financial

"Includes additional shares due to dividend reinvestment."

Dividend reinvestment is when the money earned from a company's profit sharing, called dividends, is automatically used to buy more shares of that company instead of being received as cash. This process helps investors grow their holdings over time without extra effort, much like using earned interest to buy more of a savings account. It encourages long-term investment growth by continuously increasing the amount of shares owned.

Separation from Service financial

"The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service."

Form 4 Insider Transactions: What Each Field Means →

05/15/2026 - 04:16 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

FRIEL ROBERT F

(Last)

(First)

(Middle)

C/O XYLEM INC.

301 WATER STREET SE

(Street)

WASHINGTON

DISTRICT OF COLUMBIA

20003

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Xylem Inc. [ XYL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/14/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	05/14/2026		A		2,481⁽¹⁾	A	$116.88	38,706⁽²⁾	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Reflects an award of restricted stock units pursuant to the Xylem 2011 Omnibus Incentive Plan (Amended and Restated February 24, 2016) that are scheduled to vest in full on the trading day prior to the 2027 Annual Meeting of Shareholders. The Reporting Person has elected to defer the settlement of the RSU Award until Separation from Service.

2. Includes additional shares due to dividend reinvestment.

	/s/ Mike Nazario, by power of attorney for Robert F. Friel	05/14/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Xylem (XYL) report for Robert F. Friel?

Xylem reported that director Robert F. Friel received an equity award of 2,481 restricted stock units of common stock. The award is compensation under the company’s incentive plan, not an open-market purchase, and increases his direct holdings to 38,706 shares after the grant.

How many Xylem (XYL) shares were granted in the latest RSU award?

The filing shows a grant of 2,481 restricted stock units tied to Xylem common stock at a reference value of $116.88 per share. These units will convert into shares upon settlement, adding to the director’s existing holdings once they are ultimately delivered.

When do Robert F. Friel’s new Xylem (XYL) RSUs vest?

The restricted stock units are scheduled to vest in full on the trading day immediately before Xylem’s 2027 Annual Meeting of Shareholders. Vesting marks when the award becomes earned, although the actual share delivery is deferred until the director’s Separation from Service.

What does deferring settlement of Xylem (XYL) RSUs until Separation from Service mean?

Deferring settlement means the director will not receive the underlying Xylem shares at vesting, but instead upon his Separation from Service. The RSUs still vest on the set date, yet actual share delivery and any related taxable event are postponed until his departure.